Advanced RCC: Safety and Efficacy of IO/TKI Combination Therapies
Genitourinary oncologists discuss the safety and efficacy of IO/TKI and IO/IO combination therapies in advanced renal cell carcinoma.
Source: curetoday.com
Keynote 426 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Keynote 426. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Keynote 426 Today - Breaking & Trending Today
Dr. Zhang on the Selection of Immunotherapy-Based Regimens in Metastatic RCC
Tian Zhang, MD, MHS, discusses the selection of first-line immunotherapy-based treatments for patients with metastatic renal cell carcinoma.
Source: onclive.com
Front Line Trials in Advanced RCC
Renal cell carcinoma experts discuss clinical trials, evaluating immunotherapies and tyrosine kinase inhibitors in the front line setting of advanced RCC.
Source: onclive.com